ArticleCureus2021

Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.

Keith D Eaton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.